Molecular tests are far superior to rapid antigen tests—and now you can get them for home use. Last week, I was about to go on a date, and because I'm severely immunocompromised, we agreed he would ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Researchers have developed a working prototype of a PCR test for monkeypox that provides accurate, easy-to-read results The test works with a compact, portable system developed for COVID-19 ...

Minute Molecular Diagnostics, a biotech spinout from Northwestern University that says it’s created rapid PCR COVID-19 tests, has received emergency use authorization for its product from the U.S.

Since the start of the COVID-19 pandemic in the United States, over 46 million positive coronavirus test results have been reported to the U.S. Centers for Disease Control and Prevention (CDC). When ...

At this point in the pandemic, you or someone you know has probably received at least one COVID-19 test. But do you know which kind of test you got and the strengths and weaknesses of these different ...

Molecular testing, or molecular diagnostics, refers to a group of tests that look at the genetic material in a specimen. It can detect genetic risk factors for certain diseases or provide evidence of ...

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.

If you buy something from a Verge link, Vox Media may earn a commission. See our ethics statement. Victoria Song is a senior reporter focusing on wearables, health tech, and more with 13 years of ...

As SARS-C0V-2 variants emerged, researchers developed a PCR test that uses molecular beacons not only to diagnose COVID-19 infection, but also to identify the specific variant causing that infection.

After the start of the SARS-C0V-2 pandemic, investigators from ResearchPath LLC and their collaborators at Rutgers University quickly dedicated resources to develop accurate and reliable COVID-19 ...